Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Effect of the apolipoprotein E epsilon4 allele on the efficacy and tolerability of galantamine in the treatment of Alzheimer's disease.

Dementia and geriatric cognitive disorders - 1 Jan 2006

Suh Guk-Hee, Jung Hee Yeon, Lee Chang Uk, Oh Byoung Hoon, Lee Sang-Kyu, Lee NamJin, Kim JaeHyun, Kee Baik Seok, Ko Daekwan, Kim Young-Hoon, Ju Young-Su, Hong InJa, Choi Sungku

Abstract excerpt

OBJECTIVE: To investigate the effect of the apolipoprotein E (ApoE) epsilon4 allele on the efficacy and tolerability of galantamine treatment. METHODS: A total of 202 patients with mild to moderate Alzheimer's disease participated in a 16-week, prospective, multi-center, randomized, double-blind galantamine trial in a Korean population. Patients were assessed at baseline and after 4, 8 and 16 weeks of randomized...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer Disease
Share to Apolipoprotein E4

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Apolipoproteins E

Share to Delusions

Share to Double-Blind Method

Share to Hallucinations

Share to Neuropsychological Tests

Share to Treatment Outcome

Source

Identifiers

PMID: 16254428
DOI: 10.1159/000089217

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Effect of the apolipoprotein E epsilon4 allele on the efficacy and tolerability of galantamine in the treatment of Alzheimer's disease.PMID 16254428Read ↗

APOE genotype: no influence on galantamine treatment efficacy nor on rate of decline in Alzheimer's disease.Semantic proximity Read ↗

Apolipoprotein E epsilon4 allele increases risk for psychotic symptoms in Alzheimer's disease.Semantic proximity Read ↗

ApoE epsilon4 allele is associated with incidental hallucinations and delusions in patients with AD.Semantic proximity Read ↗

Association between the APOE genotype and psychopathologic symptoms in Alzheimer's disease.Semantic proximity Read ↗

Dose dependent effect of APOE epsilon4 on behavioral symptoms in frontal lobe dementia.Semantic proximity Read ↗

Effect of ApoE genotype on response to donepezil in patients with Alzheimer's disease.Semantic proximity Read ↗

The apolipoprotein E epsilon4 allele and antidepressant efficacy in cognitively intact elderly depressed patients.Semantic proximity Read ↗

Delusion symptoms are associated with ApoE epsilon4 allelic variant at the early stage of Alzheimer's disease with late onset.Semantic proximity Read ↗

The apolipoprotein E epsilon 4 allele increases the risk of drug-induced hallucinations in Parkinson's disease.Semantic proximity Read ↗

Apolipoprotein E genotype influences presence and severity of delusions and aggressive behavior in Alzheimer disease.Semantic proximity Read ↗

Apolipoprotein E genotype and noncognitive symptoms in Alzheimer's disease.Semantic proximity Read ↗

The apolipoprotein E epsilon 4 allele is not associated with psychiatric symptoms or extrapyramidal signs in probable Alzheimer's disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.